Veterinary Medicines

PERFIKAN 134 MG/1200 MG SOLUTION POUR SPOT-ON POUR CHIENS MOYENS

Authorised
  • Fipronil
  • Permethrin
Download as PDF

Product identification

Medicine name:
PERFIKAN 134 MG/1200 MG SOLUTION POUR SPOT-ON POUR CHIENS MOYENS
PERFIKAN 134 MG/1200 MG SOLUTION POUR SPOT-ON POUR CHIENS MOYENS
Active substance:
  • Fipronil
  • Permethrin
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    134.20
    milligram(s)
    /
    1.00
    Pipette
  • Permethrin
    1199.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Boîte de 1 plaquette thermoformée de 2 pipettes de 2,2 mL
  • Boîte de 2 plaquettes thermoformées de 2 pipettes de 2,2 mL
  • Boîte de 3 plaquettes thermoformées de 2 pipettes de 2,2 mL
  • Boîte de 1 plaquette thermoformée de 1 pipette de 2,2 mL

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfamed
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/7389398 1/2014
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0373/003
Concerned member states:
  • Italy
  • Netherlands
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."